Contact

All Stories

  1. Whole-genome sequencing of ocular Chlamydia trachomatis isolates from Gadarif State, Sudan

    Article • Parasites & Vectors, November 2019, Springer Science + Business Media

    Dr Martin Holland

  2. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal

    Article • Parasites & Vectors, October 2019, Springer Science + Business Media

    Dr Martin Holland

  3. The conjunctival transcriptome in Ethiopians after trichiasis surgery: associations with the development of eyelid contour abnormalities and the effect of oral doxycycline treatment

    Article • Wellcome Open Research, September 2019, Faculty of 1000, Ltd.

    Dr Martin Holland

  4. Conjunctival Microbiome-Host Responses Are Associated With Impaired Epithelial Cell Health in Both Early and Late Stages of Trachoma

    Article • Frontiers in Cellular and Infection Microbiology, August 2019, Frontiers

    Dr Martin Holland

  5. Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and NK Cell Function

    Article • The Journal of Immunology, August 2019, The American Association of Immunologists

    Dr Martin Holland

  6. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community

    Article • PLoS Neglected Tropical Diseases, July 2019, PLOS

    Dr Martin Holland

  7. Pathway-Wide Genetic Risks in Chlamydial Infections Overlap between Tissue Tropisms: A Genome-Wide Association Scan

    Article • Mediators of Inflammation, June 2018, Hindawi Publishing Corporation

    Dr Martin Holland

  8. Is Trachoma disease severity linked to ocular Chlamydia trachomatis pathogen strain variation

    Article • Genome Medicine, February 2018, Springer Science + Business Media

    Dr Martin Holland

  9. Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection

    Article • Parasites & Vectors, February 2018, Springer Science + Business Media

    Dr Martin Holland

  10. Evaluation of a Chlamydia trachomatis-specific, commercial, real-time PCR for use with ocular swabs

    Article • Parasites & Vectors, February 2018, Springer Science + Business Media

    Dr Martin Holland

  11. Active Trachoma Cases in the Solomon Islands Have Varied Polymicrobial Community Structures but Do Not Associate with Individual Non-Chlamydial Pathogens of the Eye

    Article • Frontiers in Medicine, January 2018, Frontiers

    Dr Martin Holland

  12. An outbreak of acute haemorrhagic conjunctivitis associated with coxsackievirus A24 variant in The Gambia, West Africa

    Article • BMC Research Notes, December 2017, Springer Science + Business Media

    Dr Martin Holland

  13. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa

    Article • Parasites & Vectors, December 2017, Springer Science + Business Media

    Dr Martin Holland

  14. Pathways-wide genetic risks in Chlamydial infections overlap between tissue tropisms: A genome-wide association scan

    Article • October 2017, Cold Spring Harbor Laboratory Press

    Dr Martin Holland

  15. Immunofibrogenic Gene Expression Patterns in Tanzanian Children with Ocular Chlamydia trachomatis Infection, Active Trachoma and Scarring: Baseline Results of a 4-Year Longitudinal Study

    Article • Frontiers in Cellular and Infection Microbiology, September 2017, Frontiers

    Dr Martin Holland

  16. Genome-wide profiling of humoral immunity and pathogen genes under selection identifies immune evasion tactics of Chlamydia trachomatis during ocular infection

    Article • Scientific Reports, August 2017, Springer Science + Business Media

    Dr Martin Holland

  17. Reduced-cost Chlamydia trachomatis -specific multiplex real-time PCR diagnostic assay evaluated for ocular swabs and use by trachoma research programmes

    Article • Journal of Microbiological Methods, August 2017, Elsevier

    Dr Martin Holland

  18. Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal

    Article • BMC Public Health, July 2017, Springer Science + Business Media

    Dr Martin Holland

  19. Persistence of Innate Immune Pathways in Late Stage Human Bacterial and Fungal Keratitis: Results from a Comparative Transcriptome Analysis

    Article • Frontiers in Cellular and Infection Microbiology, May 2017, Frontiers

    Dr Martin Holland

  20. Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: a cross-sectional population-based study

    Article • Pathogens and Disease, May 2017, Oxford University Press (OUP)

    Dr Martin Holland

  21. Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control

    Article • BMC Microbiology, March 2017, Springer Science + Business Media

    Dr Martin Holland

  22. Profiling and validation of individual and patterns of Chlamydia trachomatis-specific antibody responses in trachomatous trichiasis

    Article • Parasites & Vectors, March 2017, Springer Science + Business Media

    Dr Martin Holland

  23. miRNAs that associate with conjunctival inflammation and ocular Chlamydia trachomatis infection do not predict progressive disease

    Article • Pathogens and Disease, February 2017, Oxford University Press (OUP)

    Dr Martin Holland

  24. Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies

    Article • PLoS Neglected Tropical Diseases, January 2017, PLOS

    Dr Martin Holland

  25. The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment

    Article • PLoS Neglected Tropical Diseases, October 2016, PLOS

    Dr Martin Holland

  26. Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease

    Article • PLoS Neglected Tropical Diseases, August 2016, PLOS

    Dr Martin Holland

  27. Mycobacterium leprae Activates Toll-Like Receptor-4 Signaling and Expression on Macrophages Depending on Previous Bacillus Calmette-Guerin Vaccination

    Article • Frontiers in Cellular and Infection Microbiology, July 2016, Frontiers

    Dr Martin Holland

  28. Differential frequency of NKG2C/KLRC2 deletion in distinct African populations and susceptibility to Trachoma: a new method for imputation of KLRC2 genotypes from SNP genotyping data

    Article • Human Genetics, June 2016, Springer Science + Business Media

    Dr Martin Holland

  29. Increased Epithelial Expression of CTGF and S100A7 with Elevated Subepithelial Expression of IL-1β in Trachomatous Trichiasis

    Article • PLoS Neglected Tropical Diseases, June 2016, PLOS

    Dr Martin Holland

  30. Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells

    Article • PLoS Neglected Tropical Diseases, May 2016, PLOS

    Dr Martin Holland

  31. Can corneal pannus with trachomatous inflammation – follicular be used in combination as an improved specific clinical sign for current ocular Chlamydia trachomatis infection?

    Article • Parasites & Vectors, January 2016, Springer Science + Business Media

    Dr Martin Holland

  32. Inverse relationship between microRNA-155 and -184 expression with increasing conjunctival inflammation during ocular Chlamydia trachomatis infection

    Article • BMC Infectious Diseases, December 2015, Springer Science + Business Media

    Dr Martin Holland

  33. Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: a genome wide association study

    Article • Scientific Reports, November 2015, Springer Science + Business Media

    Dr Martin Holland

  34. Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies

    Article • PLoS ONE, October 2015, PLOS

    Dr Martin Holland

  35. Pathogenesis of Progressive Scarring Trachoma in Ethiopia and Tanzania and Its Implications for Disease Control: Two Cohort Studies

    Article • PLoS Neglected Tropical Diseases, May 2015, PLOS

    Dr Martin Holland

  36. Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study

    Article • PLoS Neglected Tropical Diseases, April 2015, PLOS

    Dr Martin Holland

  37. Serology for Trachoma Surveillance after Cessation of Mass Drug Administration

    Article • PLoS Neglected Tropical Diseases, February 2015, PLOS

    Dr Martin Holland

  38. Trachoma and Ocular Chlamydial Infection in the Era of Genomics

    Article • Mediators of Inflammation, January 2015, Hindawi Publishing Corporation

    Dr Martin Holland

  39. Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control

    Article • BMC Public Health, November 2014, Springer Science + Business Media

    Dr Martin Holland

  40. Whole-genome enrichment and sequencing of Chlamydia trachomatisdirectly from clinical samples

    Article • BMC Infectious Diseases, November 2014, Springer Science + Business Media

    Dr Martin Holland

  41. The conjunctival microbiome in health and trachomatous disease: a case control study

    Article • Genome Medicine, November 2014, Springer Science + Business Media

    Dr Martin Holland

  42. Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors

    Article • PLoS Neglected Tropical Diseases, August 2014, PLOS

    Dr Martin Holland

  43. Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau

    Article • PLoS Neglected Tropical Diseases, June 2014, PLOS

    Dr Martin Holland

  44. Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia

    Article • Bulletin of the World Health Organization, April 2014, WHO Press

    Dr Martin Holland

  45. Will droplet digital PCR become the test of choice for detecting and quantifying ocularChlamydia trachomatisinfection? Maybe

    Article • Expert Review of Molecular Diagnostics, March 2014, Taylor & Francis

    Dr Martin Holland

  46. Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3

    Article • PLoS Neglected Tropical Diseases, March 2014, PLOS

    Dr Martin Holland

  47. Towards a safe and effective chlamydial vaccine: Lessons from the eye

    Article • Vaccine, March 2014, Elsevier

    Dr Martin Holland

  48. Effect of azithromycin mass drug administration for trachoma on spleen rates in Gambian children

    Article • Tropical Medicine & International Health, January 2014, Wiley

    Dr Martin Holland

  49. Killer-cell Immunoglobulin-like Receptor gene linkage and copy number variation analysis by droplet digital PCR

    Article • Genome Medicine, January 2014, Springer Science + Business Media

    Dr Martin Holland

  50. Plasmid Copy Number and Disease Severity in Naturally Occurring Ocular Chlamydia trachomatis Infection

    Article • Journal of Clinical Microbiology, November 2013, ASM Journals

    Dr Martin Holland

  51. In vivo confocal microscopy and histopathology of the conjunctiva in trachomatous scarring and normal tissue: a systematic comparison

    Article • British Journal of Ophthalmology, August 2013, BMJ

    Dr Martin Holland

  52. Association between Ocular Bacterial Carriage and Follicular Trachoma Following Mass Azithromycin Distribution in The Gambia

    Article • PLoS Neglected Tropical Diseases, July 2013, PLOS

    Dr Martin Holland

  53. Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia

    Article • PLoS Neglected Tropical Diseases, June 2013, PLOS

    Dr Martin Holland

  54. Development and Evaluation of a Next-Generation Digital PCR Diagnostic Assay for Ocular Chlamydia trachomatis Infections

    Article • Journal of Clinical Microbiology, May 2013, ASM Journals

    Dr Martin Holland

  55. Conjunctival MicroRNA Expression in Inflammatory Trachomatous Scarring

    Article • PLoS Neglected Tropical Diseases, March 2013, PLOS

    Dr Martin Holland

  56. Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis

    Article • PLoS Neglected Tropical Diseases, February 2013, PLOS

    Dr Martin Holland

  57. Biogeography of the ecosystems of the healthy human body

    Article • Genome Biology, January 2013, Springer Science + Business Media

    Dr Tatiana A Vishnivetskaya, Dr Martin Holland

  58. Eyescores: an open platform for secure electronic data and photographic evidence collection in ophthalmological field studies

    Article • British Journal of Ophthalmology, December 2012, BMJ

    Dr Martin Holland

  59. Post-Operative Recurrent Trachomatous Trichiasis Is Associated with Increased Conjunctival Expression of S100A7 (Psoriasin)

    Article • PLoS Neglected Tropical Diseases, December 2012, PLOS

    Mr Bayeh Abera Beyene, Dr Martin Holland

  60. A Diagnostics Platform for the Integrated Mapping, Monitoring, and Surveillance of Neglected Tropical Diseases: Rationale and Target Product Profiles

    Article • PLoS Neglected Tropical Diseases, July 2012, PLOS

    Dr Martin Holland

  61. Genome-Wide Identification ofChlamydia trachomatisAntigens Associated with Trachomatous Trichiasis

    Article • Investigative Ophthalmology & Visual Science, May 2012, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Martin Holland

  62. Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing

    Article • Nature Genetics, March 2012, Springer Science + Business Media

    Professor Julian Parkhill, Dr Martin Holland

  63. Innate Immune Responses and Modified Extracellular Matrix Regulation Characterize Bacterial Infection and Cellular/Connective Tissue Changes in Scarring Trachoma

    Article • Infection and Immunity, October 2011, ASM Journals

    Dr Martin Holland

  64. Active Trachoma Is Associated with Increased Conjunctival Expression ofIL17Aand Profibrotic Cytokines

    Article • Infection and Immunity, September 2011, ASM Journals

    Dr Martin Holland

  65. Diagnostic Accuracy of a Prototype Point-of-Care Test for Ocular Chlamydia trachomatis under Field Conditions in The Gambia and Senegal

    Article • PLoS Neglected Tropical Diseases, August 2011, PLOS

    Dr Martin Holland

  66. Trachoma Prevalence and Associated Risk Factors in The Gambia and Tanzania: Baseline Results of a Cluster Randomised Controlled Trial

    Article • PLoS Neglected Tropical Diseases, November 2010, PLOS

    Dr Martin Holland

  67. Conjunctival Transcriptome in Scarring Trachoma

    Article • Infection and Immunity, October 2010, ASM Journals

    Dr Martin Holland

  68. Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities

    Article • PLoS Neglected Tropical Diseases, October 2010, PLOS

    Dr Martin Holland

  69. Trichiasis Surgery in The Gambia: A 4-Year Prospective Study

    Article • Investigative Ophthalmology & Visual Science, October 2010, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Martin Holland

  70. Human Conjunctival Transcriptome Analysis Reveals the Prominence of Innate Defense in Chlamydia trachomatis Infection

    Article • Infection and Immunity, September 2010, ASM Journals

    Dr Martin Holland

  71. Pathway-Focused Arrays Reveal Increased Matrix Metalloproteinase-7 (Matrilysin) Transcription in Trachomatous Trichiasis

    Article • Investigative Ophthalmology & Visual Science, August 2010, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Martin Holland

  72. Phylogenetic Analysis of Chlamydia trachomatis Tarp and Correlation with Clinical Phenotype

    Article • Infection and Immunity, July 2010, ASM Journals

    Dr Martin Holland

  73. Conjunctival Expression of Matrix Metalloproteinase and Proinflammatory Cytokine Genes after Trichiasis Surgery

    Article • Investigative Ophthalmology & Visual Science, July 2010, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Martin Holland

  74. Haptoglobin and Sickle Cell Polymorphisms and Risk of Active Trachoma in Gambian Children

    Article • PLoS ONE, June 2010, PLOS

    Dr Martin Holland

  75. Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?

    Article • PLoS Neglected Tropical Diseases, December 2009, PLOS

    Dr Martin Holland

  76. Innate immunity in ocular Chlamydia trachomatis infection: contribution of IL8 and CSF2 gene variants to risk of trachomatous scarring in Gambians

    Article • BMC Medical Genetics, December 2009, Springer Science + Business Media

    Dr Martin Holland

  77. When Can Antibiotic Treatments for Trachoma Be Discontinued? Graduating Communities in Three African Countries

    Article • PLoS Neglected Tropical Diseases, June 2009, PLOS

    Dr Martin Holland

  78. The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control

    Article • PLoS Neglected Tropical Diseases, June 2009, PLOS

    Professor Maria-Gloria Basáñez, Dr Martin Holland

  79. Revealing the History of Sheep Domestication Using Retrovirus Integrations

    Article • Science, April 2009, American Association for the Advancement of Science

    Professor Massimo Palmarini, Dr Martin Holland

  80. Estimating Household and Community Transmission of Ocular Chlamydia trachomatis

    Article • PLoS Neglected Tropical Diseases, March 2009, PLOS

    Professor Maria-Gloria Basáñez, Dr Martin Holland

  81. Co-evolution of genomes and plasmids within Chlamydia trachomatis and the emergence in Sweden of a new variant strain

    Article • BMC Genomics, January 2009, Springer Science + Business Media

    Professor Julian Parkhill, Dr Martin Holland

  82. Risk factors for active trachoma in The Gambia

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, December 2008, Oxford University Press (OUP)

    Dr Martin Holland

  83. Chlamydia trachomatis ompA Variants in Trachoma: What Do They Tell Us?

    Article • PLoS Neglected Tropical Diseases, September 2008, PLOS

    Dr Martin Holland

  84. Analysis of flow cytometry data using an automatic processing tool

    Article • Cytometry Part A, September 2008, Wiley

    Dr Martin Holland

  85. Two Doses of Azithromycin to Eliminate Trachoma in a Tanzanian Community

    Article • New England Journal of Medicine, April 2008, New England Journal of Medicine (NEJM/MMS)

    Dr Martin Holland

  86. Pathogenic Diversity amongChlamydia trachomatisOcular Strains in Nonhuman Primates Is Affected by Subtle Genomic Variations

    Article • The Journal of Infectious Diseases, February 2008, Oxford University Press (OUP)

    Dr Martin Holland

  87. Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation

    Article • Human Molecular Genetics, October 2007, Oxford University Press (OUP)

    Dr Martin Holland

  88. FOXP3 gene expression in a tuberculosis case contact study

    Article • Clinical & Experimental Immunology, April 2007, Wiley

    Moses Lugos, Dr Martin Holland

  89. Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians

    Article • Genes & Immunity, March 2007, Springer Science + Business Media

    Dr Martin Holland

  90. Chlamydial Positivity of Nasal Discharge at Baseline Is Associated with Ocular Chlamydial Positivity 2 Months following Azithromycin Treatment

    Article • Investigative Ophthalmology & Visual Science, November 2006, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Martin Holland

  91. Conjunctival FOXP3 Expression in Trachoma: Do Regulatory T Cells Have a Role in Human Ocular Chlamydia trachomatis Infection?

    Article • PLoS Medicine, August 2006, PLOS

    Dr Martin Holland

  92. A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatisinfection

    Article • BMC Medical Genetics, April 2006, Springer Science + Business Media

    Dr Martin Holland

  93. The Frequency of Chlamydia trachomatis Major Outer Membrane Protein-Specific CD8+ T Lymphocytes in Active Trachoma Is Associated with Current Ocular Infection

    Article • Infection and Immunity, March 2006, ASM Journals

    Dr Martin Holland

  94. Conjunctival Chlamydial 16S Ribosomal RNA Expression in Trachoma: Is Chlamydial Metabolic Activity Required for Disease to Develop?

    Article • Clinical Infectious Diseases, February 2006, Oxford University Press (OUP)

    Dr Martin Holland

  95. Temporal cytokine gene expression patterns in subjects with trachoma identify distinct conjunctival responses associated with infection

    Article • Clinical & Experimental Immunology, November 2005, Wiley

    Dr Martin Holland

  96. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study

    Article • The Lancet, October 2005, Elsevier

    Dr Martin Holland

  97. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study

    Article • The Lancet, April 2005, Elsevier

    Dr Martin Holland

  98. Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci

    Article • Genes & Immunity, March 2005, Springer Science + Business Media

    Dr Martin Holland

  99. An index of community ocular Chlamydia trachomatis load for control of trachoma

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, March 2005, Oxford University Press (OUP)

    Dr Martin Holland

  100. Mass Treatment and the Effect on the Load ofChlamydia trachomatisInfection in a Trachoma-Hyperendemic Community

    Article • Investigative Ophthalmology & Visual Science, January 2005, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Martin Holland

  101. Th2 induction by Nippostrongylus secreted antigens in mice deficient in B cells, eosinophils or MHC Class I-related receptors

    Article • Immunology Letters, January 2005, Elsevier

    Dr Martin Holland

  102. Cytokine and Fibrogenic Gene Expression in the Conjunctivas of Subjects from a Gambian Community Where Trachoma Is Endemic

    Article • Infection and Immunity, December 2004, ASM Journals

    Dr Martin Holland

  103. Mass Treatment with Single-Dose Azithromycin for Trachoma

    Article • New England Journal of Medicine, November 2004, New England Journal of Medicine (NEJM/MMS)

    Dr Martin Holland

  104. Selective maturation of dendritic cells byNippostrongylus brasiliensis-secreted proteins drives Th2 immune responses

    Article • European Journal of Immunology, November 2004, Wiley

    Dr Martin Holland

  105. Which Members of a Community Need Antibiotics to Control Trachoma? ConjunctivalChlamydia trachomatisInfection Load in Gambian Villages

    Article • Investigative Ophthalmology & Visual Science, October 2003, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Martin Holland

  106. Plasmodium falciparum infection of the placenta affects newborn immune responses

    Article • Clinical & Experimental Immunology, September 2003, Wiley

    Dr Martin Holland

  107. Strategies for control of trachoma: observational study with quantitative PCR

    Article • The Lancet, July 2003, Elsevier

    Dr Martin Holland

  108. Proteins secreted by the parasitic nematodeNippostrongylus brasiliensis act as adjuvants for Th2 responses

    Article • European Journal of Immunology, July 2000, Wiley

    Dr Martin Holland

  109. Vaccination against helminth parasites - the ultimate challenge for vaccinologists?

    Article • Immunological Reviews, October 1999, Wiley

    Dr Martin Holland, Franco Falcone

  110. Early Interleukin–4: Its Role in the Switch towards a Th2 Response and IgE–Mediated Allergy

    Article • International Archives of Allergy and Immunology, January 1999, Karger Publishers

    Dr Martin Holland, Franco Falcone

  111. Parasite immunity: Pathways for expelling intestinal helminths

    Article • Current Biology, October 1998, Elsevier

    Dr Martin Holland

  112. Antibody Response to the 60‐kDa Chlamydial Heat‐Shock Protein Is Associated with Scarring Trachoma

    Article • The Journal of Infectious Diseases, January 1998, Oxford University Press (OUP)

    Dr Martin Holland

  113. Synthetic peptides based on Chlamydia trachomatis antigens identify cytotoxic T lymphocyte responses in subjects from a trachoma‐endemic population

    Article • Clinical & Experimental Immunology, January 1997, Wiley

    Dr Martin Holland

  114. Jaagsiekte retrovirus establishes a disseminated infection of the lymphoid tissues of sheep affected by pulmonary adenomatosis

    Article • Journal of General Virology, December 1996, Society for General Microbiology

    Professor Massimo Palmarini, Dr Martin Holland

  115. T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring

    Article • Clinical & Experimental Immunology, September 1996, Wiley

    Dr Martin Holland